Parasitic helminth nucleic acid molecules/and uses thereof
    1.
    发明授权
    Parasitic helminth nucleic acid molecules/and uses thereof 失效
    寄生蠕虫核酸分子及其用途

    公开(公告)号:US6114142A

    公开(公告)日:2000-09-05

    申请号:US473034

    申请日:1995-06-06

    IPC分类号: A61K39/00 C12N15/11 C12N15/30

    CPC分类号: C07K14/4354 C07K16/20

    摘要: The present invention relates to parasitic helminth proteins of about 39 kD (i.e., P39 proteins); to parasitic helminth P39 nucleic acid molecules, including those that encode such proteins; and to antibodies raised against such proteins. The present invention also includes methods to obtain such proteins, nucleic acid molecules, and antibodies. Also included in the present invention are therapeutic compositions comprising such proteins, nucleic acid molecules, and/or antibodies as well as the use of such therapeutic compositions to protect animals from diseases caused by parasitic helminths.

    摘要翻译: 本发明涉及约39kD(即P39蛋白)的寄生蠕虫蛋白; 包括寄生蠕虫P39核酸分子,包括编码这些蛋白质的那些; 以及针对这种蛋白质产生的抗体。 本发明还包括获得这些蛋白质,核酸分子和抗体的方法。 本发明还包括包含这些蛋白质,核酸分子和/或抗体的治疗组合物,以及这些治疗组合物用于保护动物免受寄生蠕虫引起的疾病的用途。

    Parasitic helminth P39 proteins, and uses thereof
    2.
    发明授权
    Parasitic helminth P39 proteins, and uses thereof 失效
    寄生蠕虫P39蛋白及其用途

    公开(公告)号:US5977306A

    公开(公告)日:1999-11-02

    申请号:US487031

    申请日:1995-06-06

    摘要: The present invention relates to parasitic helminth proteins of about 39 kD (i.e., P39 proteins); to parasitic helminth P39 nucleic acid molecules, including those that encode such proteins; and to antibodies raised against such proteins. The present invention also includes methods to obtain such proteins, nucleic acid molecules, and antibodies. Also included in the present invention are therapeutic compositions comprising such proteins, nucleic acid molecules, and/or antibodies as well as the use of such therapeutic compositions to protect animals from diseases caused by parasitic helminths.

    摘要翻译: 本发明涉及约39kD(即P39蛋白)的寄生蠕虫蛋白; 包括寄生蠕虫P39核酸分子,包括编码这些蛋白质的那些; 以及针对这种蛋白质产生的抗体。 本发明还包括获得这些蛋白质,核酸分子和抗体的方法。 本发明还包括包含这些蛋白质,核酸分子和/或抗体的治疗组合物,以及这些治疗组合物用于保护动物免受寄生蠕虫引起的疾病的用途。